<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.
Find me on:

Recent Posts

NANS 2019: Highlights and Key Takeaways

Posted by Anne Staylor on 5/7/19 7:30 AM

SmartTRAK highlights key takeaways from the recent North American Neuromodulation (NANS) 22nd annual meeting held in Las Vegas in January, including important company news, trials, technologies, and trends affecting the US market for spinal cord stimulation (SCS) and what's next in this market. This informative article also includes exclusive interviews with leading figures in Neuromodulation including Saluda Medical CEO John Parker, President Abbott Neuromodulation Keith Boetigger, Medtronic Senior VP and Pain Therapies President Marshall Stanton, and Medtronic Senior Global Product Manager for Pain Stimulation and Early Interventions Brian Ranck ...

Spotlight on Saluda Medical

In one of the most anticipated presentations at NANS 2019, Nagy Mekail, MD, PhD presented preliminary three-month results from Saluda Medical’s EVOKE US pivotal RCT (N=134), which is evaluating Saluda’s ECAP-controlled, closed-loop, Evoke SCS System. In the double-blinded study, the experimental arm (n=67) received closed-loop Evoke stimulation while the control arm (n=67) received fixed-output, open-loop Evoke SCS stimulation. At three months, the closed-loop group demonstrated superiority (Ps=0.005) having an 82.3% (51/62) success rate vs the open-loop group’s 60.3% (38/63) in 50% or greater reduction in overall Trunk and Limb VAS. The closed-loop group also met superiority (Ps=0.003) in terms of low back pain responders at three months with 80.6% demonstrating a 50% or greater reduction in back VAS versus 57.1% in the open-loop group. Of note, the closed loop Evoke group spent 91.1% of time (median % of stimuli) within the therapeutic window vs 59.5% of the time in the open-loop group.

In another presentation, Charles Brooker, MBChB presented updated results from the ongoing AVALON trial evaluating the safety and performance of 

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

Q418/FY18 Market Recap: SCS Market Slows

Posted by Anne Staylor on 4/9/19 10:12 AM

The Spinal Cord Stimulation (SCS) market saw high-teens growth in FY18, but decelerated in Q418.

The US SCS Market saw another banner year in FY18, growing +17.4% YoY. Market growth was driven by new product launches, expanding indications and ongoing demand for non-narcotic alternatives that address chronic intractable pain and the opioid epidemic.

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

SmartTRAK attending International Stroke Conference 2019

Posted by Anne Staylor on 1/23/19 10:24 AM
SmartTRAK is excited to be attending the AANS/CNS Joint Cerebrovascular Annual Meeting on Feb. 4-5, 2019 at the Sheraton Waikiki in Honolulu, Hawaii and the International Stroke Conference 2019, Feb 6-8, also in Honolulu.

Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies will be representing BioMedGPS SmartTRAK at both conferences. Please Contact Usif you would like a meeting!

Read More

Q318 SCS Market Recap: On Track for Another Record Year

Posted by Anne Staylor on 1/21/19 10:17 AM

New Products, Continued Demand Provide SCS Market Tailwinds

SmartTRAK reports that with new products providing a strong tailwind in Q318, the SCS market saw another quarter of strong double-digit growth in both the US and WW, positioning the market for another record year. 

Among the many topics covered in the Q318 SCS Market Recap are:

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, Q318 Market Recaps

Spinal Cord Stimulation: Top Trends to Watch in 2019 and Beyond

Posted by Anne Staylor on 1/15/19 12:00 PM

SmartTRAK identifies trends to watch in spinal cord stimulation 

With the start of a new year, it's time to look back at 2018 and identify continuing and emerging trends in the market for Spinal Cord Stimulation (SCS) that are likely to shape the landscape in 2019 and beyond.

So what’s on the horizon? Anne Staylor, SmartTRAK Managing Editor, gives her predictions for the top technology and market trends to watch.

Among the many interesting and informative topics covered in the article are:

Read More

Topics: Neuromodulation-Spinal Cord Stimulation

NANS 2019 Preview: SmartTRAK Interviews Todd Sitzman, MD

Posted by Anne Staylor on 1/14/19 10:00 AM

In an interview with SmartTRAK, B. Todd Sitzman, MD, MPH, President of the North American Neuromodulation Society (NANS), provides a preview of the educational opportunities, key research and emerging technologies that will be at the NANS 22nd Annual meeting to be held January 17-20, 2019 in Las Vegas, NV. Dr. Sitzman expects NANS 2019 to be the biggest meeting yet for the premier neuromodulation society, with up to 3000 attendees and 300+ abstracts presented, organized around the theme of “The Science Behind Successful Outcomes.”

To find out more about the meeting, click on the video below to listen to SmartTRAK’s interview with Dr. Sitzman, recorded via Skype from his office in Hattiesburg, Mississippi (11:53 minutes). 

Read More

Topics: Neuromodulation, SmartTRAK Interviews

SmartTRAK Attending ASRA 2018 Pain Medicine Meeting

Posted by Anne Staylor on 11/7/18 10:00 AM
SmartTRAK is excited to be attending ASRA - the American Society of Regional Anesthesia and Pain Medicine - on Nov 15-17, 2015 at the JW Marriott San Antonio Hill Country resort in San Antonio, TX.

Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies will be representing BioMedGPS SmartTRAK at the conference. 

Read More

Topics: SmartTRAK Conferences

An Interview with Medtronic's Matt Thomas

Posted by Anne Staylor on 11/6/18 11:00 AM

Medtronic’s Matt Thomas discusses the Company’s strategies for driving growth in spinal cord stimulation and plans for innovation in an interview with SmartTRAK at ASIPP 2018.

Matt Thomas, General Manager and Vice President of Medtronic’s STIM & Early Intervention business discusses the Company’s growth strategies, plans for innovation, and what’s next in spinal cord stimulation in a podcast interview with SmartTRAK at the American Society of Interventional Pain Physicians (ASIPP) 2018 held March 15-17, 2018 in Orlando, FL

Click the Podcast Link to hear the interview, recorded live at ASIPP 2018. (18:55 minutes.)

To receive a downloadable transcript, click the button below...

Read More

Topics: Neuromodulation-Spinal Cord Stimulation, SmartTRAK Interviews

SmartTRAK Attending CNS-Congress of Neurological Surgeons 2018

Posted by Anne Staylor on 10/2/18 2:28 PM
SmartTRAK is excited to be attending CNS 2018 - Congress of Neurological Surgeons - October 6-10 at George R. Brown Convention Center in Houston, TX.

SmartTRAK will be represented by Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies.

At CNS 2107, Anne did an interview with Dr. Ashwini Sharan, President of the Congress of Neurological Surgeons, on The Future of Robotic Spine Surgery, discussing current trends in robotic spine surgery, factors affecting growth in this market and future directions for this technology. To download a transcript of this fascinating interview, please click the button below.

 Download Dr. Sharan's Interview at CNS

Read More

Topics: Neurotherapies, Computer Assisted Surgery - Spine

SmartTRAK Attending SNIS 2018 - Society of NeuroInterventional Surgery Meeting

Posted by Anne Staylor on 7/20/18 12:05 PM

SmartTRAK is excited to be attending #SNIS - Society of Neuro Interventional Surgery's 15th annual meeting on July 23-26 at the Hilton San Francisco Union Square, in San Francisco, California.

SmartTRAK will be represented by Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies and Christopher McCarthy, Vice President Corporate Accounts, Orthopedics and Neuro. Please  contact us if you would like a meeting.


Read More

Topics: Neuromodulation, SmartTRAK Conferences

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts